Patient-to-Patient Diverse CLL Clinical Trial Profiles

July 2021

The goal of the Patient-to-Patient Diverse Clinical Trial Profiles program is to bridge the gap between patients who have participated in clinical trials and patients who have not yet participated for various reasons.

Program topics include:

Personalize Your Experience!

Create an account to save items and receive information curated just for you.
Create Account

This program is supported by Pharmacyclics, an AbbVie Company and Janssen and through generous donations from people like you.

Share On:

Facebook
Twitter
LinkedIn